ProCE Banner Series

Bridging IgAN Care: Nurse-Led Strategies for Management and Treatment With Novel Disease-Modifying Therapies

In this live symposium, experts in the care of IgAN will provide insights and answers on its pathophysiology, presentation, and impact, as well as recent advances in disease-modifying therapies. An interactive, expert-guided case segment will provide an opportunity for practical application of presented information.

Please note: You must be registered for the ANNA 2025 National Symposium to attend this symposium in person or virtually. You may register on the conference site.

  ANCC
Who Should Attend

This activity has been designed to meet the educational needs of nephrology nurses and nurse practitioners who care for patients with IgAN.

All Events

Bridging IgAN Care: Nurse-Led Strategies for Management and Treatment With Novel Disease-Modifying Therapies

Upcoming Events

May

03

2025

7:00 AM - 8:30 AM Pacific Time (PT)

In-person

Oregon Convention Center, 777 NE Martin Luther King Jr Blvd, Portland, Oregon 97232

7:30 AM - 8:30 AM Pacific Time (PT)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Chronic Kidney Disease.

Target Audience
This activity has been designed to meet the educational needs of nephrology nurses and nurse practitioners who care for patients with IgAN.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Differentiate the roles of complement, endothelin, and APRIL/BAFF pathways in the pathogenesis of IgAN

  • Integrate knowledge of the mechanistic differences and clinical efficacy and safety data on new and emerging IgAN therapies to individualize patient treatment plans

  • Develop nurse-led strategies for management and treatment focused on reducing proteinuria to slow disease progression and enhance patient outcomes in IgAN

Accreditation

Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hour of pharmacotherapy credit.

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies. 

Acknowledgement

Provided by

Provided by Partners for Advancing Clinical Education (Partners) 

Partners for Advancing Clinical Education (PACE) 2025

Supporters

Supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical Inc

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191